All DZIF articles
-
NewsMechanism of action of the hepatitis B and D virus cell entry inhibitor bulevirtide deciphered
An international research team has succeeded in deciphering the molecular structure of bulevirtide in complex with the HBV/HDV receptor NTCP at the molecular level.
-
NewsNeutralizing antibodies target resistant bacteria
Scientists have discovered antibodies that could lead to a highly potent treatment option of acute and chronic infections with Pseudomonas aeruginosa.
-
NewsResearchers develop targeted test for antibiotic resistance in clinical Enterobacter species
A large-scale DZIF study has achieved a breakthrough and clarified the relationships between the numerous Enterobacter species as well as optimised resistance testing.
-
NewsResearcher receives €1.5m from ERC to probe insecticide resistance in malaria transmission
Dr Victoria Ingham, a scientist at Heidelberg Medical Faculty and the German Center for Infection Research (DZIF), has been awarded an ERC Starting Grant of €1.5 million for her research on the infectious disease malaria.
